{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:49:06Z","timestamp":1790912946746,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-02861-4","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T17:03:04Z","timestamp":1654880584000},"page":"1881-1889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target"],"prefix":"10.1007","volume":"24","author":[{"given":"Somayeh","family":"Vafaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasamin","family":"Hajimomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Fakhre Yaseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-8193","authenticated-orcid":false,"given":"Firoozeh","family":"Abolhasani Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"2861_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40064-015-0943-5","volume":"4","author":"J Tom\u00e9-Amat","year":"2015","unstructured":"Tom\u00e9-Amat J, Olombrada M, Ruiz-de-la-Herr\u00e1n J, P\u00e9rez-G\u00f3mez E, Andradas C, S\u00e1nchez C, et al. Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin \u03b1-sarcin in nude mice bearing human colorectal cancer xenografts. Springerplus. 2015;4:1\u201310.","journal-title":"Springerplus"},{"key":"2861_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1158\/1535-7163.MCT-15-0647","volume":"15","author":"P Br\u00fcnker","year":"2016","unstructured":"Br\u00fcnker P, Wartha K, Friess T, Grau-Richards S, Waldhauer I, Koller CF, et al. RG7386, a novel tetravalent FAP-DR5 antibody, effectively triggers FAP-dependent, avidity-driven DR5 hyperclustering and tumor cell apoptosis. Mol Cancer Ther. 2016;15:946\u201357.","journal-title":"Mol Cancer Ther"},{"key":"2861_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2861_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.biopha.2017.12.033","volume":"98","author":"G Lei","year":"2018","unstructured":"Lei G, Xu M, Xu Z, Lu C, Tan S. Combination of novel DR5 targeting agonistic scFv antibody TR2-3 with cisplatin shows enhanced synergistic antitumor activity in vitro and in vivo. Biomed Pharmacother. 2018;98:271\u20139.","journal-title":"Biomed Pharmacother"},{"key":"2861_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4989-y","volume":"18","author":"F-R Liu","year":"2018","unstructured":"Liu F-R, Bai S, Feng Q, Pan X-Y, Song S-L, Fang H, et al. Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells. BMC Cancer. 2018;18:1\u201310.","journal-title":"BMC Cancer"},{"key":"2861_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell"},{"key":"2861_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2861_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","volume":"265","author":"SM Man","year":"2015","unstructured":"Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6\u201321.","journal-title":"Immunol Rev"},{"key":"2861_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","volume":"25","author":"D Verma","year":"2012","unstructured":"Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerb\u00e4ck C, et al. Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res. 2012;25:506\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2861_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/carcin\/bgs256","volume":"33","author":"J Ungerb\u00e4ck","year":"2012","unstructured":"Ungerb\u00e4ck J, Belenki D, Jawad ul-Hassan A, Fredrikson M, Frans\u00e9n K, Elander N, et al. Genetic variation and alterations of genes involved in NF\u03baB\/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis. 2012;33:2126\u201334.","journal-title":"Carcinogenesis"},{"key":"2861_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cell.2013.10.015","volume":"155","author":"TM Kim","year":"2013","unstructured":"Kim TM, Laird PW, Park PJ. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell. 2013;155:858\u201368.","journal-title":"Cell"},{"key":"2861_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/A:1025734200635","volume":"2","author":"L Olsson","year":"2003","unstructured":"Olsson L, Lindblom A. Family history of colorectal cancer in a Sweden county. Fam Cancer. 2003;2:87\u201393.","journal-title":"Fam Cancer"},{"key":"2861_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"2861_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275\u201392.","journal-title":"Cell"},{"key":"2861_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","volume":"361","author":"SD Markowitz","year":"2009","unstructured":"Markowitz SD, Bertagnolli MM. Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449\u201360.","journal-title":"N Engl J Med"},{"key":"2861_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/328614a0","volume":"328","author":"WF Bodmer","year":"1987","unstructured":"Bodmer WF, Bailey CJ, Bodmer J, Bussey H, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987;328:614\u20136.","journal-title":"Nature"},{"key":"2861_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrc1453","volume":"4","author":"A De la Chapelle","year":"2004","unstructured":"De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769\u201380.","journal-title":"Nat Rev Cancer"},{"key":"2861_CR18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/1097-0142(196905)23:5<1210::AID-CNCR2820230530>3.0.CO;2-M","volume":"23","author":"EL Wynder","year":"1969","unstructured":"Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A. Environmental factors of cancer of the colon and rectum II. Japanese epidemiological data. Cancer. 1969;23:1210\u201320.","journal-title":"Cancer"},{"key":"2861_CR19","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.3748\/wjg.v20.i20.6055","volume":"20","author":"F Bishehsari","year":"2014","unstructured":"Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol. 2014;20:6055\u201372.","journal-title":"World J Gastroenterol"},{"key":"2861_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/01635581.2011.596642","volume":"63","author":"C Pelucchi","year":"2011","unstructured":"Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C. Alcohol consumption and cancer risk. Nutr Cancer. 2011;63:983\u201390.","journal-title":"Nutr Cancer"},{"key":"2861_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol Cell. 2002;10:417\u201326.","journal-title":"Mol Cell"},{"key":"2861_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13:397\u2013411.","journal-title":"Nat Rev Immunol"},{"key":"2861_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277:61\u201375.","journal-title":"Immunol Rev"},{"key":"2861_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biocel.2010.01.008","volume":"42","author":"M Lamkanfi","year":"2010","unstructured":"Lamkanfi M, Kanneganti TD. Nlrp3: an immune sensor of cellular stress and infection. Int J Biochem Cell Biol. 2010;42:792\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"2861_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","volume":"27","author":"TD Kanneganti","year":"2007","unstructured":"Kanneganti TD, Lamkanfi M, N\u00fa\u00f1ez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27:549\u201359.","journal-title":"Immunity"},{"key":"2861_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000510","volume":"5","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi M, Dixit VM. The inflammasomes. PLoS Pathog. 2009;5: e1000510.","journal-title":"PLoS Pathog"},{"key":"2861_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"E-K Jo","year":"2016","unstructured":"Jo E-K, Kim JK, Shin D-M, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148\u201359.","journal-title":"Cell Mol Immunol"},{"key":"2861_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/JLB.3MR0720-472RR","volume":"108","author":"C Donovan","year":"2020","unstructured":"Donovan C, Liu G, Shen S, Marshall JE, Kim RY, Alemao CA, et al. The role of the microbiome and the NLRP3 inflammasome in the gut and lung. J Leukoc Biol. 2020;108:925\u201335.","journal-title":"J Leukoc Biol"},{"key":"2861_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107556","volume":"95","author":"R Lotfi","year":"2021","unstructured":"Lotfi R, Nasiri Kalmarzi R, Rajabinejad M, Hasani S, Zamani F. The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets. Int Immunopharmacol. 2021;95: 107556.","journal-title":"Int Immunopharmacol"},{"key":"2861_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1471-4914(03)00052-2","volume":"9","author":"TT Pizarro","year":"2003","unstructured":"Pizarro TT, Arseneau KO, Bamias G, Cominelli F. Mouse models for the study of Crohn\u2019s disease. Trends Mol Med. 2003;9:218\u201322.","journal-title":"Trends Mol Med"},{"key":"2861_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","volume":"32","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379\u201391.","journal-title":"Immunity"},{"key":"2861_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010;207:1045\u201356.","journal-title":"J Exp Med"},{"key":"2861_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/ibd.21478","volume":"17","author":"SA Hirota","year":"2011","unstructured":"Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis. 2011;17:1359\u201372.","journal-title":"Inflamm Bowel Dis"},{"key":"2861_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2010.02.012","volume":"32","author":"J Dupaul-Chicoine","year":"2010","unstructured":"Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KS, McIntire CR, LeBlanc PM, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 2010;32:367\u201378.","journal-title":"Immunity"},{"key":"2861_CR35","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1126\/science.1104815","volume":"307","author":"F Radtke","year":"2005","unstructured":"Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science. 2005;307:1904\u20139.","journal-title":"Science"},{"key":"2861_CR36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/gut.2007.142588","volume":"57","author":"LA Simms","year":"2008","unstructured":"Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn\u2019s disease. Gut. 2008;57:903\u201310.","journal-title":"Gut"},{"key":"2861_CR37","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1136\/gut.2003.032805","volume":"53","author":"J Wehkamp","year":"2004","unstructured":"Wehkamp J, Harder J, Weichenthal M, Schwab M, Sch\u00e4ffeler E, Schlee M, et al. NOD2 (CARD15) mutations in Crohn\u2019s disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658\u201364.","journal-title":"Gut"},{"key":"2861_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","volume":"20","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev. 2010;20:65\u201371.","journal-title":"Curr Opin Genet Dev"},{"key":"2861_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11888-017-0373-6","volume":"13","author":"AG Long","year":"2017","unstructured":"Long AG, Lundsmith ET, Hamilton KE. Inflammation and Colorectal Cancer. Curr Colorectal Cancer Rep. 2017;13:341\u201351.","journal-title":"Curr Colorectal Cancer Rep"},{"key":"2861_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10753-021-01575-z","volume":"45","author":"A Rezaiemanesh","year":"2022","unstructured":"Rezaiemanesh A, Mahmoudi M, Amirzargar AA, Vojdanian M, Babaie F, Mahdavi J, et al. Upregulation of unfolded protein response and ER stress-related IL-23 production in M1 macrophages from ankylosing spondylitis patients. Inflammation. 2022;45:665\u201376.","journal-title":"Inflammation"},{"key":"2861_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","volume":"150","author":"VA Rathinam","year":"2012","unstructured":"Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell. 2012;150:606\u201319.","journal-title":"Cell"},{"key":"2861_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41564-018-0318-0","volume":"4","author":"A Mathur","year":"2019","unstructured":"Mathur A, Feng S, Hayward JA, Ngo C, Fox D, Atmosukarto II, et al. A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome. Nat Microbiol. 2019;4:362\u201374.","journal-title":"Nat Microbiol"},{"key":"2861_CR43","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1097\/MIB.0000000000000151","volume":"20","author":"BK Davis","year":"2014","unstructured":"Davis BK, Philipson C, Hontecillas R, Eden K, Bassaganya-Riera J, Allen IC. Emerging significance of NLRs in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:2412\u201332.","journal-title":"Inflamm Bowel Dis"},{"key":"2861_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","volume":"15","author":"SM Man","year":"2018","unstructured":"Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15:721\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2861_CR45","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1349-7006.2003.tb01386.x","volume":"94","author":"T Tanaka","year":"2003","unstructured":"Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003;94:965\u201373.","journal-title":"Cancer Sci"},{"key":"2861_CR46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/cmi.2017.14","volume":"14","author":"H Zhu","year":"2017","unstructured":"Zhu H, Cao X. NLR members in inflammation-associated carcinogenesis. Cell Mol Immunol. 2017;14:403\u20135.","journal-title":"Cell Mol Immunol"},{"key":"2861_CR47","doi-asserted-by":"publisher","first-page":"21635","DOI":"10.1073\/pnas.1016814108","volume":"107","author":"B Hu","year":"2010","unstructured":"Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci. 2010;107:21635\u201340.","journal-title":"Proc Natl Acad Sci"},{"key":"2861_CR48","first-page":"481","volume":"92","author":"A Pandey","year":"2019","unstructured":"Pandey A, Shen C, Man SM. Inflammasomes in colitis and colorectal cancer: mechanism of action and therapies. Yale J Biol Med. 2019;92:481\u201398.","journal-title":"Yale J Biol Med"},{"key":"2861_CR49","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.4049\/jimmunol.1002046","volume":"185","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol. 2010;185:4912\u201320.","journal-title":"J Immunol"},{"key":"2861_CR50","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1084\/jem.20160462","volume":"214","author":"V Neudecker","year":"2017","unstructured":"Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737\u201352.","journal-title":"J Exp Med"},{"key":"2861_CR51","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.immuni.2015.08.013","volume":"43","author":"J Dupaul-Chicoine","year":"2015","unstructured":"Dupaul-Chicoine J, Arabzadeh A, Dagenais M, Douglas T, Champagne C, Morizot A, et al. The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity. 2015;43:751\u201363.","journal-title":"Immunity"},{"key":"2861_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","volume":"17","author":"M Moossavi","year":"2018","unstructured":"Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A. Role of the NLRP3 inflammasome in cancer. Mol Cancer. 2018;17:158.","journal-title":"Mol Cancer"},{"key":"2861_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2326-6066.CIR-16-0269","volume":"5","author":"R Karki","year":"2017","unstructured":"Karki R, Man SM, Kanneganti TD. Inflammasomes and cancer. Cancer Immunol Res. 2017;5:94\u20139.","journal-title":"Cancer Immunol Res"},{"key":"2861_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10787-022-00933-z","volume":"30","author":"H Azadeh","year":"2022","unstructured":"Azadeh H, Alizadeh-Navaei R, Rezaiemanesh A, Rajabinejad M. Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis. Inflammopharmacology. 2022;30:435\u201351.","journal-title":"Inflammopharmacology"},{"key":"2861_CR55","doi-asserted-by":"publisher","first-page":"21635","DOI":"10.1073\/pnas.1016814108","volume":"107","author":"B Hu","year":"2010","unstructured":"Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA. 2010;107:21635\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2861_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bcp.2016.02.017","volume":"105","author":"Q Du","year":"2016","unstructured":"Du Q, Wang Q, Fan H, Wang J, Liu X, Wang H, et al. Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome. Biochem Pharmacol. 2016;105:42\u201354.","journal-title":"Biochem Pharmacol"},{"key":"2861_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1375640","volume":"7","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Guo Q, Zhao K, Zhou Y, Li W, Pan C, et al. Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy. Oncoimmunology. 2017;7: e1375640.","journal-title":"Oncoimmunology"},{"key":"2861_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.yexcr.2016.03.009","volume":"342","author":"H Wang","year":"2016","unstructured":"Wang H, Wang Y, Du Q, Lu P, Fan H, Lu J, et al. Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells. Exp Cell Res. 2016;342:184\u201392.","journal-title":"Exp Cell Res"},{"key":"2861_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2018.10.030","volume":"442","author":"Q Deng","year":"2019","unstructured":"Deng Q, Geng Y, Zhao L, Li R, Zhang Z, Li K, et al. NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver. Cancer Lett. 2019;442:21\u201330.","journal-title":"Cancer Lett"},{"key":"2861_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152737","volume":"216","author":"B Wang","year":"2020","unstructured":"Wang B, Li H, Wang X, Zhu X. The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer. Pathol Res Pract. 2020;216: 152737.","journal-title":"Pathol Res Pract"},{"key":"2861_CR61","first-page":"483","volume":"24","author":"Y Marandi","year":"2021","unstructured":"Marandi Y, Hashemzade S, Tayebinia H, Karimi J, Zamani A, Khodadadi I. NLRP3-inflammasome activation is associated with epithelial-mesenchymal transition and progression of colorectal cancer. Iran J Basic Med Sci. 2021;24:483\u201392.","journal-title":"Iran J Basic Med Sci"},{"key":"2861_CR62","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2174\/1871520620666200220112741","volume":"20","author":"X Shao","year":"2020","unstructured":"Shao X, Lei Z, Zhou C. NLRP3 promotes colorectal cancer cell proliferation and metastasis via regulating epithelial mesenchymal transformation. Anticancer Agents Med Chem. 2020;20:820\u20137.","journal-title":"Anticancer Agents Med Chem"},{"key":"2861_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020189","author":"LB Mutala","year":"2021","unstructured":"Mutala LB, Deleine C, Karakachoff M, Dansette D, Ducoin K, Oger R, et al. The caspase-1\/IL-18 axis of the inflammasome in tumor cells: a modulator of the Th1\/Tc1 response of tumor-infiltrating t lymphocytes in colorectal cancer. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13020189.","journal-title":"Cancers (Basel)"},{"key":"2861_CR64","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1158\/0008-5472.CAN-20-3827","volume":"81","author":"X Wang","year":"2021","unstructured":"Wang X, Jia Y, Wen L, Mu W, Wu X, Liu T, et al. Porphyromonas gingivalis promotes colorectal carcinoma by activating the hematopoietic NLRP3 inflammasome. Cancer Res. 2021;81:2745\u201359.","journal-title":"Cancer Res"},{"key":"2861_CR65","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4161\/auto.28374","volume":"10","author":"W Guo","year":"2014","unstructured":"Guo W, Sun Y, Liu W, Wu X, Guo L, Cai P, et al. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy. 2014;10:972\u201385.","journal-title":"Autophagy"},{"key":"2861_CR66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbrc.2021.04.076","volume":"558","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li F, Wang L, Lou Y. A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptor. Biochem Biophys Res Commun. 2021;558:147\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"2861_CR67","doi-asserted-by":"publisher","unstructured":"Shi F, Wei B, Lan T, Xiao Y, Quan X, Chen J, et al. Low NLRP3 expression predicts a better prognosis of colorectal cancer. 2021. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20210280.","DOI":"10.1042\/BSR20210280"},{"key":"2861_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.674340","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y, Yu Y, Yang C, Wang Z, Yang Y, Wang C, et al. Atractylenolide I inhibits NLRP3 inflammasome activation in colitis-associated colorectal cancer via suppressing Drp1-mediated mitochondrial fission. Front Pharmacol. 2021;12: 674340.","journal-title":"Front Pharmacol"},{"key":"2861_CR69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2020.08.033","volume":"491","author":"S Qiao","year":"2020","unstructured":"Qiao S, Lv C, Tao Y, Miao Y, Zhu Y, Zhang W, et al. Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer. Cancer Lett. 2020;491:162\u201379.","journal-title":"Cancer Lett"},{"key":"2861_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030516","author":"IC Chung","year":"2019","unstructured":"Chung IC, OuYang CN, Yuan SN, Lin HC, Huang KY, Wu PS, et al. Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11030516.","journal-title":"Nutrients"},{"key":"2861_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0003-9861(91)90587-9","volume":"290","author":"PA Harper","year":"1991","unstructured":"Harper PA, Prokipcak RD, Bush LE, Golas CL, Okey AB. Detection and characterization of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human colon adenocarcinoma cell line LS180. Arch Biochem Biophys. 1991;290:27\u201336.","journal-title":"Arch Biochem Biophys"},{"key":"2861_CR72","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3945\/jn.108.104125","volume":"139","author":"I Erdelyi","year":"2009","unstructured":"Erdelyi I, Levenkova N, Lin EY, Pinto JT, Lipkin M, Quimby FW, et al. Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J Nutr. 2009;139:2072\u20138.","journal-title":"J Nutr"},{"key":"2861_CR73","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/SLA.0000000000001874","volume":"264","author":"CJ D\u00edaz-D\u00edaz","year":"2016","unstructured":"D\u00edaz-D\u00edaz CJ, Ronnekleiv-Kelly SM, Nukaya M, Geiger PG, Balbo S, Dator R, et al. The aryl hydrocarbon receptor is a repressor of inflammation-associated colorectal tumorigenesis in mouse. Ann Surg. 2016;264:429\u201336.","journal-title":"Ann Surg"},{"key":"2861_CR74","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/carcin\/bgt083","volume":"34","author":"T Ikuta","year":"2013","unstructured":"Ikuta T, Kobayashi Y, Kitazawa M, Shiizaki K, Itano N, Noda T, et al. ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice. Carcinogenesis. 2013;34:1620\u20137.","journal-title":"Carcinogenesis"},{"key":"2861_CR75","doi-asserted-by":"publisher","unstructured":"Wang Z, Tang X, Wu X, Yang M, Wang W, Wang L, et al. Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis. 2019. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20190357.","DOI":"10.1042\/BSR20190357"},{"key":"2861_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115672","volume":"428","author":"L Xu","year":"2021","unstructured":"Xu L, Cai P, Li X, Wu X, Gao J, Liu W, et al. Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice. Toxicol Appl Pharmacol. 2021;428: 115672.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2861_CR77","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1158\/2326-6066.CIR-20-1019","volume":"9","author":"L Fan","year":"2021","unstructured":"Fan L, Xu C, Ge Q, Lin Y, Wong CC, Qi Y, et al. A. Muciniphila Suppresses Colorectal Tumorigenesis by Inducing TLR2\/NLRP3-Mediated M1-Like TAMs. Cancer Immunol Res. 2021;9:1111\u201324.","journal-title":"Cancer Immunol Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02861-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:12:24Z","timestamp":1668384744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02861-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":77,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02861-4","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}